Back to search

Netherlands· NL-e44a897b658f

Duloxetine Viatris 60 mg, harde maagsapresistente capsules

A duloxetine product containing duloxetinehydrochloride, registered in Netherlands by Viatris Limited. The same ATC class is registered in 16 of our 19 countries.

ATC N06AX21

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDuloxetine Viatris 60 mg, harde maags…ATCN06AX21REGISTER NO.NL-e44a897b658fPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Duloxetine is registered in 16 of 19 countries.

Countries holding a registration under ATC N06AX21 (duloxetine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Duloxetine · ATC N06AX21

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of duloxetine costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.28 in United States to $1.57 in Switzerland — a ×5.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Duloxetine · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.57
  • IT Italy$0.67
  • US United States$0.28 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DULOXETINEHYDROCHLORIDE
Manufacturer
Viatris Limited
Country
Netherlands (NL)
ATC code
N06AX21
ATC class
Duloxetine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/15/1010

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

501 interactions on record for duloxetine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Duloxetine · interactions on record

501 records

  • 33 severe
  • 247 moderate
  • 23 minor
  • 130 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

68 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Duloxetine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All duloxetine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Dulasolan, Duloxetin +pharma
  • Belgium · Duloxetin Ab, Duloxétine Ab
  • Bulgaria · Dulasolan, Duxet
  • Cyprus · Dulox, Duloxetine Accord
  • Czechia · Dolyxan, Dulasolan
  • Germany · Dulasolan, Duloxalta
  • Denmark · Aritavi, Duciltia
  • Estonia · Dulsevia, Onelar
  • Spain · Dedulox 30 Mg Cápsulas Duras Gastrorresistentes Efg, Dedulox 60 Mg
  • Finland · Duloxetin Stada, Duloxetine Accord
  • France · Duloxetine Accord, Duloxetine Almus
  • United Kingdom (Northern Ireland) · Depalta, Duciltia
  • Greece · Duciltia, Duloxetine Liconsa
  • Croatia · Dolyxan, Duloksetin Pliva
  • Hungary · Duciltia, Dulodet
  • Ireland · Duloxetine Accord, Duloxetine Clonmel
  • Iceland · Aritavi, Cymbalta
  • Italy · Alikres, Dulex
  • Liechtenstein · Cymbalta, Duloxetine Lilly
  • Lithuania · Dulsevia
  • Luxembourg · Duloxetin Ab, Duloxetine Liconsa
  • Latvia · Dulsevia
  • Malta · Onelar
  • Norway · Cymbalta, Duloxetin Krka
  • Poland · Aurodulox, Depratal
  • Portugal · Duloxetina Alter, Duloxetina Amperlem
  • Romania · Dozzex, Duloxetină Dr. Reddy's
  • Sweden · Aritavi, Dulmis
  • Slovenia · Duloksetin Sandoz, Dulsevia
  • Slovakia · Duloxetin Krka, Duloxetin Krka, D.D., Novo Mesto

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd708f07-57dc-43b0-a4b8-c2ffcbf4aaa2
GET /v1/drugs/dd708f07-57dc-43b0-a4b8-c2ffcbf4aaa2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maagsapresistente capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/duloxetine-viatris-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Duloxetine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp116254",
  "excipients": [
    "BRILJANTBLAUW FCF (E 133)",
    "CROSPOVIDON (E 1202)",
    "DIETHYLFTALAAT",
    "GELATINE (E 441)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "HYPROMELLOSEFTALAAT",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL 400",
    "MACROGOL 6000",
    "MAÏSZETMEEL",
    "NATRIUMHYDROXIDE (E 524)",
    "POVIDON (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROSE",
    "SACCHAROSE",
    "SCHELLAK (E 904)",
    "SUIKERZETMEELBOLLETJES",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT"
  ],
  "substances": [
    "DULOXETINEHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2015/06/19",
  "procedure_number": "EMEA/H/C/003981",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/15/1010",
  "additional_monitoring": "N"
}

See everything about duloxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.